PLATE, CRANIOPLASTY, PREFORMED, ALTERABLE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2018-06-20 for PLATE, CRANIOPLASTY, PREFORMED, ALTERABLE manufactured by Oberdorf Synthes Produktions Gmbh.

Event Text Entries

[111651657] This information is unknown. Date of infection is unknown. This report is for an unknown synpor implant/unknown lot. Part and lot numbers are unknown; udi number is unknown. Date of implantation is unknown date between 2003 and 2013. Date of explantation is unknown date 6 months after implantation. Complainant part is not expected to be returned for manufacturer review/investigation. Without a lot number the device history records review could not be completed. The investigation could not be completed; no conclusion could be drawn, as no product was received. (b)(4). Device was used for treatment, not diagnosis. If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
Patient Sequence No: 1, Text Type: N, H10


[111651658] This report is being filed after the review of the following journal article. Jung b. K. Et al (2016) orbital floor reconstruction using a tensor fascia lata sling after total maxillectomy. Journal of cranio-maxillo-facial surgery. Volume 44. Pages 648-653. (korea, south) the aim of this study is to present the outcomes of orbital floor reconstruction using tensor fascia lata slings after total maxillectomy and to compare these results to orbital floor reconstruction using alloplastic implants. Between 2003 and 2013, 19 patients (12 males and 7 females with mean age of 56 years) who underwent maxillectomy with orbital floor removal for malignancies and subsequent reconstruction were retrospectively analyzed. Five patients had orbital floor reconstructions with tensor fascia lata slings (group a), and 14 patients had reconstructions with alloplastic implants (group b). Out of the 14 patients in group b, two were implanted with an unknown synthes ultra-high molecular weight polyethylene. The mean follow-up was 57 months. A (b)(6) male had signs of infection in the inferior orbital area plate exposure after 4 months. After 6 months, the plate was removed and the orbital floor was reconstructed with a reverse temporalis muscle flap and rib bone grafts. The patient recovered well, but the tumor recurred in the supero-temporal orbital area after the initial surgery. The following complications were reported in patients under group b. In this group, patients were implanted with either an alloplastic implant or with an unknown synthes synpor? : 13 cases of wound complications, 1 case of infection, 3 cases of plate exposure, 4 cases of infection. Five (5) cases of plate exposure: 3 cases of enophthalmos, 9 cases of ectropion, 8 cases of re-operation. This report is for an unknown synthes synpor?. This report is 1 of 2 for (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8030965-2018-54430
MDR Report Key7618974
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2018-06-20
Date of Report2018-05-24
Date Mfgr Received2018-06-20
Date Added to Maude2018-06-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMICHAEL COTE
Manufacturer Street1302 WRIGHTS LANE EAST
Manufacturer CityWEST CHESTER PA 19380
Manufacturer CountryUS
Manufacturer Postal19380
Manufacturer Phone6107195000
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Generic NamePLATE, CRANIOPLASTY, PREFORMED, ALTERABLE
Product CodeGWO
Date Received2018-06-20
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerOBERDORF SYNTHES PRODUKTIONS GMBH
Manufacturer AddressEIMATTSTRASSE 3 OBERDORF 4436 SZ 4436


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-06-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.